TPG Capital’s $207 Million Acquisition of Healthscope’s Asia Pathology Business

Allens has advised Healthscope Limited on the deal

Australia’s leading private healthcare operators, executed the sale of its Asian pathology operations in Singapore, Malaysia and Vietnam to funds managed by TPG Capital Asia for $207 million.

Healthscope’s Asian pathology operations consist of 39 pathology laboratories across Singapore, Malaysia and Vietnam, operating under the Gribbles Pathology and Quest Laboratories brands. The divestment follows Healthscope’s sale of its Australian pathology business in 2015 and Australian medical centres business in 2017 – both transactions on which Allens advised.

Allens advised with a team including Emin Altiparmak (Picture) (Lead Partner – Corporate); Michelle Bennett, Managing Associate (Corporate); Annabelle Aland, Managing Associate (Real Estate); Julian Holland, Associate (Corporate); Joanne Pak, Lawyer (Corporate) and Dougald Coulson (Real Estate).

Involved fees earner: Emin Altiparmak – Allens; Michelle Bennett – Allens; Annabelle Aland – Allens;

Law Firms: Allens;

Clients: Healthscope Ltd.;


Author: Michael Patrini